$76.53
0.16% day before yesterday
NYSE, Nov 01, 09:00 pm CET
ISIN
US63633D1046
Symbol
NHI
Sector
Industry

National Health Investors, Inc. Target price 2024 - Analyst rating & recommendation

National Health Investors, Inc. Classifications & Recommendation:

Buy
50%
Hold
50%

National Health Investors, Inc. Price Target

Target Price $85.86
Price $76.45
Potential
Number of Estimates 7
7 Analysts have issued a price target National Health Investors, Inc. 2025 . The average National Health Investors, Inc. target price is $85.86. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 4 Analysts recommend National Health Investors, Inc. to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the National Health Investors, Inc. stock has an average upside potential 2025 of . Most analysts recommend the National Health Investors, Inc. stock at Buy or hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 322.36 272.63
12.81% 15.43%
EBITDA Margin 78.02% 95.56%
0.55% 22.49%
Net Margin 42.15% 47.76%
87.47% 13.31%

8 Analysts have issued a sales forecast National Health Investors, Inc. 2024 . The average National Health Investors, Inc. sales estimate is

$273m
Unlock
. This is
17.12% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$312m 5.24%
Unlock
, the lowest is
$239m 27.34%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $322m 12.81%
2024
$273m 15.43%
Unlock
2025
$284m 4.35%
Unlock
2026
$313m 10.05%
Unlock
2027
$258m 17.66%
Unlock
2028
$259m 0.43%
Unlock

6 Analysts have issued an National Health Investors, Inc. EBITDA forecast 2024. The average National Health Investors, Inc. EBITDA estimate is

$261m
Unlock
. This is
1.31% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$267m 3.86%
Unlock
, the lowest is
$257m 0.22%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $251m 12.19%
2024
$261m 3.59%
Unlock
2025
$279m 6.96%
Unlock
2026
$278m 0.20%
Unlock
2027
$261m 6.05%
Unlock

EBITDA Margin

2023 78.02% 0.55%
2024
95.56% 22.49%
Unlock
2025
97.95% 2.50%
Unlock
2026
88.83% 9.31%
Unlock
2027
101.35% 14.09%
Unlock

3 National Health Investors, Inc. Analysts have issued a net profit forecast 2024. The average National Health Investors, Inc. net profit estimate is

$130m
Unlock
. This is
2.37% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$131m 2.73%
Unlock
, the lowest is
$130m 1.97%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $136m 111.49%
2024
$130m 4.18%
Unlock
2025
$136m 4.23%
Unlock
2026
$143m 5.01%
Unlock

Net Margin

2023 42.15% 87.47%
2024
47.76% 13.31%
Unlock
2025
47.71% 0.10%
Unlock
2026
45.52% 4.59%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 3.13 3.00
111.49% 4.15%
P/E 25.49
EV/Sales 17.04

3 Analysts have issued a National Health Investors, Inc. forecast for earnings per share. The average National Health Investors, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$3.00
Unlock
. This is
2.39% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$3.01 2.73%
Unlock
, the lowest is
$2.99 2.05%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $3.13 111.49%
2024
$3.00 4.15%
Unlock
2025
$3.13 4.33%
Unlock
2026
$3.28 4.79%
Unlock

P/E ratio

Current 26.05 33.45%
2024
25.49 2.15%
Unlock
2025
24.45 4.08%
Unlock
2026
23.29 4.74%
Unlock

Based on analysts' sales estimates for 2024, the National Health Investors, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

17.04
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
12.86
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 14.12 32.71%
2024
17.04 20.69%
Unlock
2025
16.33 4.17%
Unlock
2026
14.84 9.14%
Unlock
2027
18.02 21.44%
Unlock
2028
17.94 0.43%
Unlock

P/S ratio

Current 10.66 53.28%
2024
12.86 20.66%
Unlock
2025
12.32 4.17%
Unlock
2026
11.20 9.14%
Unlock
2027
13.60 21.44%
Unlock
2028
13.54 0.43%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today